Vyvanse Does Not Cause Penile Discharge—This Requires Urgent STI Evaluation
Penile discharge is NOT a known side effect of Vyvanse (lisdexamfetamine) and should be presumed to be urethritis from a sexually transmitted infection until proven otherwise. This patient needs immediate testing for gonorrhea and chlamydia with nucleic acid amplification tests (NAATs), and empiric treatment should be initiated promptly 1.
Why This Is Not Related to Vyvanse
The FDA label for Vyvanse 2 does not list penile discharge among its adverse effects. While Vyvanse has documented sexual side effects including:
- Increased libido and hypersexual behaviors (particularly in males) 3
- Erectile dysfunction 3
- Priapism (rare but serious) 4
- Ejaculatory dysfunction 3
Penile discharge is conspicuously absent from this profile. The research literature on lisdexamfetamine's sexual effects focuses on erectile function, ejaculation timing, and libido changes—never discharge 5, 3.
What This Actually Represents
Penile discharge in a sexually active 37-year-old male indicates urethritis, most commonly from:
- Chlamydia trachomatis (most common)
- Neisseria gonorrhoeae (second most common)
- Non-gonococcal urethritis from other organisms
Immediate Management Algorithm
1. Testing (Do Not Delay Treatment)
- First-catch urine for NAAT testing for gonorrhea and chlamydia
- Urethral swab if discharge is present for Gram stain (looking for WBC with gram-negative intracellular diplococci)
- HIV and syphilis testing 1
2. Empiric Treatment (Start Immediately)
Recommended first-line regimen 1:
- Azithromycin 1 g orally as a single dose
- OR
- Doxycycline 100 mg orally twice daily for 7 days
The single-dose azithromycin offers superior compliance and can be directly observed 1.
3. Sexual Activity Restrictions
- Abstain from sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen AND symptoms have resolved 1
- Abstain until all sex partners are treated to prevent reinfection 1
4. Partner Management
- All sexual partners within the preceding 60 days must be evaluated, tested, and empirically treated 1
- Expedited partner therapy is an acceptable alternative approach 1
Critical Pitfalls to Avoid
Do not attribute this to Vyvanse and delay appropriate treatment. Untreated urethritis can lead to:
- Epididymitis
- Prostatitis
- Transmission to partners
- In female partners: pelvic inflammatory disease, infertility, ectopic pregnancy
Do not stop the Vyvanse. There is no indication to discontinue ADHD treatment for this unrelated condition. The patient's ADHD management should continue unchanged.
Follow-Up Considerations
- If symptoms persist after treatment completion, re-evaluate for treatment failure, reinfection, or resistant organisms 1
- Repeat testing at 3-6 months is recommended due to high reinfection rates in men with documented chlamydia or gonorrhea 1
- Consider chronic prostatitis/chronic pelvic pain syndrome if symptoms persist beyond 3 months despite appropriate treatment 1
The Bottom Line
This is a straightforward case of presumed infectious urethritis that coincidentally occurs in a patient taking Vyvanse. The temporal association is just that—coincidental. Treat the STI aggressively, continue the ADHD medication, and counsel the patient about safe sexual practices.